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Abstract: A synthetic route to cis -2-methyl-4-oxo-6- alkylpiperidines has been developed using a 6-endo-trig cyclization of E-enones. The base-mediated intramolecular cyclization was found to be general for both alkyl and aryl substituted enones, providing the corresponding 4-oxopiperidines in high yields (80-89%). Stereoselective reduction of the 2,6-cis-disubstituted 4-oxopiperidines then gave the 2,4,6-cis,cis-trisubstituted 4-hydroxypiperidines in high diastereoselectivity. The general nature of this approach was demonstrated with the synthesis of the natural products, spruce alkaloid and (+)-241D.
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The piperidine ring system is found as a key structural element in a vast array of natural products and pharmaceutically active compounds. 1 Among the various structural classes, 2,6-cis-dialkylpiperidines have been isolated from plants, insects and amphibians and have demonstrated a wide range of biological activities. 1 These include cis,cis -2-methyl-4-hydroxy-6 -alkylpiperidines such as spruce alkaloid (1), isolated from the Colorado blue spruce, Picea pungens ( Figure 1 ). 2 Interestingly, the absolute configuration of spruce alkaloid (1) is not known. The structure was determined from GC-MS data, a racemic synthesis and analogy to similar 2,6-disubstituted piperidines from conifers, which generally possess the same absolute configuration at the C2-methyl center. 2 Other examples of this class of alkaloid include (+)-241D (2), isolated from the skin of the Panamanian poison frog Dendrobates speciosus. 3 (+)-241D (2) and the corresponding 4-piperidone 3 are potent inhibitors of binding of As a result of significant biological activity and the common cis,cis -2-methyl-4-hydroxy-6- alkylpiperidine framework, there have been significant interest in developing approaches for the synthesis of these alkaloids. In particular, many strategies have been reported for the asymmetric synthesis of (+)-241D (2). 5 These include a highly efficient, six-step approach reported by Ma and Sun 4 used for the preparation of other 2,6-cis-dialkylpiperidine alkaloids such as (+)-prosophylline and (+)-241D. 7 In recent years, we have reported stereoselective methods for the synthesis of highly substituted pipecolic acid analogues using a 6-endo-trig cyclization of enone-derived -amino acids. 8, 9 We found that formation of a particular cyclization conformer using substrate control generated either 2,6-trans-or 2,6-cis-6-substituted 4-oxopipecolic acids. We were interested in investigating a similar approach for the synthesis of cis . Herein, we now report the use of a 6-endo-trig cyclization of amine-substituted enones for the preparation of a series of 2-methyl-4-hydroxy-6-alkylpiperidines and the application of this approach for the eight-step synthesis of spruce alkaloid and (+)-241D.
Scheme 1. Methods for the Synthesis of cis,cis-2-Methyl-4-hydroxy-6-alkylpiperidines
6 Enones 9 were then converted to 2,6-disubstituted 4-oxopiperidines 10 and 11 by acidic removal of the Boc-protecting group, followed by cyclization of the resulting amine by treatment with DIPEA (Table 1 ). In our previous study involving 6-endo-trig cyclization of -amino acid derived enones, the use of this two-step approach gave the corresponding 2,6-cis-6-substituted 4-oxopipecolic acids as the major products, although with modest diastereoselectivity. 9 As expected of enones 9, with a smaller methyl group to impart facial selectivity during the conjugate addition, the 2,6-cis-and 2,6-trans-6-substituted 4-oxopiperidines were formed in essentially a 1:1 ratio. 15, 16 However, these structurally more simple substrates were found to undergo the two-stage deprotection and cyclization in a highly efficient and general manner, forming the two diastereomers in highly consistent yields (80-89%), irrespective of the enone side-chain. Furthermore, 4-oxopiperidines 10 and 11 were easily separated by column chromatography, allowing the isolation of the 2,6-cis-diastereomer in 41-46% yields over two steps. In all cases, this gave a diastereoselective ratio of 9:1 with the major cis,cis-4-hydroxypiperidines isolated in 68-91% yields. This completed the total synthesis of spruce alkaloid (1) and (+)-241D (2) in eight steps and in 26% and 21% overall yield, respectively, as well as various novel cis,cis -2-methyl-4-hydroxy-6-arylpiperidines (12c-12f) . The relative stereochemistry of all novel compounds generated from the 6-endo-trig cyclization and the stereoselective reduction was confirmed using NOE experiments.
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Scheme 3. Stereoselective Reduction of 4-Piperidones 10 a a Isolated yields of cis,cis-4-hydroxypiperidines are shown.
In summary, a short and efficient synthesis of a series of amino substituted E-enones was developed from an L-aspartic acid analogue using hydrodehalogenation and HWE reactions as the key steps. These 8 compounds were investigated as substrates for a base-mediated 6-endo-trig cyclization. The two-stage deprotection-cyclization process was highly efficient and tolerant of both aliphatic and aryl side chains.
Stereoselective reduction of the resulting 2,6-cis-4-oxopiperidines completed a new approach for the preparation of the natural products, spruce alkaloid and (+)-241D, as well as the synthesis of a series of novel cis,cis -2-methyl-4-hydroxy-6-arylpiperidines .
EXPERIMENTAL SECTION
All reagents and starting materials were obtained from commercial sources and used as received. All dry solvents were purified using a solvent purification system. All reactions were performed in ovendried glassware under an atmosphere of argon unless otherwise stated. Brine refers to a saturated solution of sodium chloride. Flash column chromatography was performed using silica gel 60 (40-63 m). Aluminium-backed plates pre-coated with silica gel 60F254 were used for thin layer chromatography and were visualized with a UV lamp or by staining with potassium permanganate. 1 H NMR spectra were recorded on a NMR spectrometer at either 400 or 500 MHz and data are reported as follows: chemical shift in ppm relative to tetramethylsilane or the solvent as the internal standard (CDCl3,  7.26 ppm or CD3OD,  3.31 ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet or overlap of nonequivalent resonances, integration). 13 C NMR spectra were recorded on a NMR spectrometer at either 101 or 126 MHz and data are reported as follows: chemical shift in ppm relative to tetramethylsilane or the solvent as internal standard (CDCl3,  77.0 ppm or CD3OD,  49.0 ppm), multiplicity with respect to hydrogen (deduced from DEPT experiments, C, CH, CH2 or CH3). IR spectra were recorded on a FTIR spectrometer; wavenumbers are indicated in cm -1 .
Mass spectra were recorded using electrospray techniques. HRMS spectra were recorded using a dualfocusing magnetic analyzer mass spectrometer. Melting points are uncorrected. Optical rotations were determined as solutions irradiating with the sodium D line (λ = 589 nm) using a polarimeter. Methyl (3S)-3-(tert-butoxycarbonylamino)-4-hydroxybutanoate (5). 19 To a solution of N-Boc-Laspartic acid 4-methyl ester (4) 
Methyl (3S)-3-(tert-butoxycarbonylamino)-4-iodobutanoate (6)
. 10 To a suspension of imidazole (4.11 g, 60.4 mmol) and triphenylphosphine (11.9 g, 45. 3 mmol) in a mixture of diethyl ether and dichloromethane (2:1, 100 mL) at 0 °C was added iodine (11.5 g, 45.3 mmol) 
Methyl (3R)-3-(tert-butoxycarbonylamino)butanoate (7)
. 20 A solution of methyl (3S)-3-(tertbutoxycarbonylamino)-4-iodobutanoate (6) (9.33 g, 27.2 mmol), N,N-diisopropylethylamine (7.11 mL, 40.8 mmol) and 10% Pd/C (2.89 g, 2.72 mmol) in methanol (50 mL) were purged with hydrogen for 0.5 h. The reaction mixture was stirred under an atmosphere of hydrogen for 18 h at room temperature. The mixture was then filtered through Celite and the filtrate was concentrated in vacuo. The resulting residue was dissolved in dichloromethane (100 mL) and washed with a saturated solution of sodium hydrogen carbonate (50 mL), 1 M hydrochloric acid (50 mL), brine (50 mL), dried over MgSO4, filtered and concentrated in vacuo to give methyl (3R)-3-(tert-butoxycarbonylamino)butanoate (7) as a colorless oil (5.87 g, 99%) . Spectroscopic data were consistent with the literature. 20 Rf 0 
(4R)-4-(tert-Butoxycarbonylamino)-1-(dimethyloxyphosphoryl)pentan-2-one (8).
Dimethyl methylphosphonate (3.74 mL, 34.5 mmol) was dissolved in tetrahydrofuran (100 mL) and cooled to −78
°C under an argon atmosphere. n-Butyl lithium (2.5 M, in hexane, 13.8 mL, 34.5 mmol) was added dropwise and the mixture was stirred for 0.3 h. A solution of methyl (3R)-3-(tertbutoxycarbonylamino)butanoate (7) (3.00 g, 13.8 mmol) in tetrahydrofuran (20 mL) was added dropwise. The resulting mixture was then stirred at −78 °C for 0.5 h and allowed to warm to 0 °C over a period of 1 h. The reaction was quenched with a saturated aqueous solution of ammonium chloride (4 mL) and extracted with ethyl acetate (2 × 50 mL). The combined organic layers were combined, washed with brine (100 mL), dried (MgSO4), filtered and concentrated in vacuo. Purification by flash column chromatography on silica gel, eluting with 40% ethyl acetate in dichloromethane gave (4R)-4-(tert- (8) 
(2R,5E)-8-Phenyl-2-(tert-butoxycarbonylamino)-4-oxooct-5-ene (9c). The reaction was carried out
according to the procedure for the synthesis of 9a using (4R)-4-(tert-butoxycarbonylamino)-1- (8) 
(2R,5E)-6-(Pyridin-3'-yl)-2-(tert-butoxycarbonylamino)-4-oxohex-5-ene (9h). The reaction was
carried out according to the procedure for the synthesis of 9a using (4R)-4-(tert-butoxycarbonylamino)- (8) 
(2R,6S)-2-Methyl-6-propylpiperidin-4-one (10a) and (2R,6R)-2-methyl-6-propylpiperidin-4-one (11a).
(2R,5E)-2-(tert-Butoxycarbonylamino)-4-oxonona-5-ene (9a) (0.298 g, 1.17 mmol) was dissolved in dichloromethane (12 mL) and trifluoroacetic acid (0.890 mL, 11.7 mmol) was added dropwise. The mixture was stirred for 1.5 h at room temperature. The mixture was then concentrated in vacuo and the crude residue was redissolved in methanol (12 mL) and cooled to 0 °C. N,NDiisopropylethylamine (0.300 mL, 1.75 mmol) was added dropwise and the mixture was allowed to warm to room temperature and left to stir for 2 h. The mixture was then diluted with ethyl acetate (15 mL) and washed with a saturated aqueous solution of sodium hydrogen carbonate (10 mL) and brine (10 mL = 8.0 Hz, 2H), 3.17 (dqd, J = 11.9, 6.2, 2.7 Hz, 1H), 1H), 2H), 7.52 (dd, J = 8.6, 1.5 Hz, 1H), 4H) 14.2, 4.9, 1.4 Hz, 1H), 2.74 (ddd, J = 14.4, 5.3, 1.4 Hz, 1H), 2.81 (ddd, J = 14.4, 6.9, 1.4 Hz, 1H), 1H), 4.65 (dd, J = 6.9, 5.3 Hz, 1H), 3H) (2R,4S,6S)-2-Methyl-6-nonylpiperidin-4-ol (2). 5a The reaction was carried out according to the procedure for the synthesis of 1 using (2R,6S)-2-methyl-6-nonylpiperidin-4-one (10b) (0.028 g, 0.12 mmol). Purification by flash column chromatography on silica gel, eluting with 10% methanol/1% triethylamine in ethyl acetate gave (2R,4S,6S)-2-methyl-6-nonylpiperidin-4-ol (2) (2R,4S,6S)-2-Methyl-6-(2'-phenylethyl)piperidin-4-ol (12a). 21 The reaction was carried out according to the procedure for the synthesis of 1 using (2R,6S)-2-methyl-6-(2'-phenylethyl)piperidin-4-one (10c)
Hz, 1H), 8.50 (dd, J = 4.8, 1.8 Hz, 1H), 8.58 (d, J = 1.8 Hz, 1H 
